• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JMIR Res Protoc . A prospective cohort of clinical and epidemiological characteristics of COVID-19 patients post-discharge in Tehran, Iran (Tele-CO

tetano

Editor, Senior Moderator
JMIR Res Protoc


. 2021 Jan 5.
doi: 10.2196/23316. Online ahead of print.
A prospective cohort of clinical and epidemiological characteristics of COVID-19 patients post-discharge in Tehran, Iran (Tele-COVID-19): Research protocol and baseline findings


Laya Jalilian Khave[SUP] 1 [/SUP], Mohammad Vahidi[SUP] 1 [/SUP], Dorsa Shirini[SUP] 1 [/SUP], Ghazal Sanadgol[SUP] 1 [/SUP], Farzad Ashrafi[SUP] 2 [/SUP], Mehran Arab-Ahmadi[SUP] 3 [/SUP], Alireza Fatemi[SUP] 4 [/SUP], Minoosh Shabani[SUP] 4 5 [/SUP], Taha Hassanzadeh[SUP] 1 [/SUP], Behandokht Rezaei[SUP] 1 [/SUP], Alireza Zali[SUP] 4 [/SUP], Davood Ommi[SUP] 4 [/SUP], Shabnam Nohesara[SUP] 6 [/SUP], Reza Jalili Khoshnood[SUP] 4 [/SUP], Saeed Abdi[SUP] 4 [/SUP], Ali Pirsalehi[SUP] 4 [/SUP], Ehsan Masarat[SUP] 7 [/SUP], Mostafa Shokoohi[SUP] 8 9 [/SUP], Mohammad Karamouzian[SUP] 10 9 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) was declared a pandemic on March 11, 2020. Given the severe shortage of hospital beds leading to early discharges and insufficient patient education regarding home care routines and isolation protocols, close follow-up with patients and their immediate relatives is an integral part of care transition from hospital to home among COVID-19 patients.
Objective: We designed the Tele-COVID-19 prospective cohort to follow-up COVID-19 patients in Tehran, Iran, to help improve healthcare delivery and recording of patients' clinical profile post-discharge.
Methods: All adult patients admitted to COVID-19 wards of teaching hospitals of Tehran, Iran, were eligible to participate. At baseline, patients were recruited from four major hospitals from March 9, 2020, to May 20, 2020. Telephone follow-ups led by volunteer medical students were made on days 1, 2, 3, 5, 7, 10, and 14 post-discharge. Data were collected on a range of socio-demographic, epidemiological, and clinical characteristics using a standard questionnaire.
Results: Out of 950 confirmed COVID-19 patients who were approached, 823 consented and were enrolled in the cohort (response rate = 86.6%). A total of 449 (54.5%) participants were male and the mean (SD) age of participants was 50.1 (12.6). During the initial data collection phase, >5000 phone calls were made and over 577 reports of critical cases in need of urgent medical attention were recorded.
Conclusions: Tele-COVID-19 will provide the patients with sufficient education on homecare and isolation as well as medical advice on care and proper use of drugs. In addition, by preventing unnecessary hospital returns and diagnosis of household transmissions at the earliest stages, this cohort would help with effective disease management in resource-restricted settings.
 
Back
Top Bottom